premise: US shares edged up Monday while crude oil prices plummeted below 60 dollars.
  Guidant sued Johnson & Johnson to complete the 25.4 billion dollars purchase of Guidant after J&J missed the Nov. 4 deadline for closing the transaction. Guidant, the heart-device maker facing US probes and New York state fraud claims, is seeking an order for J&J to consummate the transaction. Guidant fell 1.40 dollars to 57.52 dollars, while J&J rose 55 cents to 61.43 dollars.
  At the close of trading, the blue-chip Dow Jones Industrial Average rose 55.47, or 0.53 percent, to 10,586.23, its highest close since Sept. 16.
   What might Guidant obtain by suing Johnson & Johnson?
hypothesis: an order for J&J to consummate the transaction